Lp(a) is a lipoprotein that is associated with increased cardiovascular risk. One in five people has it elevated.
The only way to know if it is high is to perform a simple analysis of blood. In 95% of cases, its value is determined genetically, but variability is already being seen by various factors such as postmenopause and kidney disease. Lp(A) particles are 6 times more atherogenic than those in the majority of the population when it is at normal values. It is known that between 20% and 25% of the Argentine population has Lp (a) - and the same is true for the rest of the world. The study is booming, driven by the development of therapies to lower its levels, but there are still many unresolved questions about Lp('a') The most common way to measure it is to do a simple blood analysis, but experts advise measuring it at least once in your life, if you have it in your body.